Speakers
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Farideh Bischoff, Ph.D.
Chief Medical Officer & Global Head of Diagnostics
Heranova Lifesciences Inc.
Melissa Bonner, Ph.D.
Chief Scientific Officer
nChroma Bio Inc.
Luciana Borio, M.D.
Venture Partner
ARCH Venture Partners
Serdar Bulun, M.D.
Professor
Northwestern University Feinberg School of Medicine
Mark Bunnage, DPhil
SVP & Head of Global Research
Vertex
Marty Burke, M.D., Ph.D.
Professor of Chemical Innovation
University of Illinois Urbana–Champaign
Rachel Butler
President & Board Director
Catalytic Impact Foundation
Todd Carter, Ph.D.
Chief Scientific Officer
Voyager Therapeutics
Preeti Chalsani, Ph.D.
Chief Quantum Officer
Intersect Illinois
Hearn Jay Cho, M.D., Ph.D.
Chief Medical Officer
Multiple Myeloma Research Foundation
Fred Chong, Ph.D.
Professor of Computer Science
University of Chicago
Alex Cogdill, Ph.D.
Head, Strategic Initiatives, Global Business Development
Daiichi Sankyo
Peter Cornelius, Ph.D.
Senior Director, Translational Research
SynDevRx
Adam Cotton, Ph.D.
Associate
Novartis Venture Fund
Guillermo Del Angel, Ph.D.
Rare Disease and Data Science Head, Center for Genomics Research
AstraZeneca
Tracy Dooley, M.D.
Venture Partner
Institute for Follicular Lymphoma Innovation
Jakob Dupont, M.D.
Executive Partner
Sofinnova Investments
Marci English
SVP, TA Head, BioPharma and Ophthalmology Development
Astellas
Aaron Esser-Kahn, Ph.D.
Professor of Molecular Engineering
University of Chicago
Stacy Feld
Global Head, External Scientific Innovation
Johnson & Johnson
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Aaron Fluitt, Ph.D.
Sr. Dir. Technical Partnerships
PsiQuantum
Ruixan Gao, Ph.D.
Assistant Professor of Chemistry and Biological Sciences
University of Illinois Chicago
Chris Garabedian
Portfolio Manager, PXV Fund and CEO,
Xontogeny
Dimitra Georganopoulou, Ph.D.
General Partner
Qral Ventures
Femida Gwadry-Sridhar, R.Ph., Ph.D.
CEO and Founder
Pulse Infoframe Inc.
Alison Handley, Ph.D.
Vice President, Head, Center for External Innovation
Astellas
Daniel Hart, Ph. D.
Chief Technology Officer
Epicrispr Biotechnologies
Chuan He, Ph.D.
Professor of Chemistry, Biochemistry, and Molecular Biology
University of Chicago
Kenny Heitritter, Ph.D.
VP of R&D
qBraid
John Higgins
Managing Director
Brain Tumor Investment Fund (BTIF)
Edward Hodgkin, Ph.D
Managing Partner
Syncona
Michelle Hoffmann
Executive Director
Chicago Biomedical Consortium
Jeffrey Hubbell, Ph.D.
Professor
New York University
Sasha Huhalov
Head of Search and Evaluation
Takeda
Ross Jeggo, Ph.D.
Head of Neurodegeneration and Emerging Research
Biogen
Alyssa Johnsen, M.D., Ph.D.
SVP, Global Therapeutic Area Head for Immunology and Oncology Development
Sanofi
Gopal Karemore Ph.D.
Global Quantum Lead in Healthcare and Life Sciences
IBM
Jamie Kasuboski, Ph.D.
Partner & Head of Research
Luma Group
Hilary Keeley
Executive Director
The Sontag Foundation
Neil Kelleher, Ph.D.
Glass Professor
Northwestern University
Shana Kelley
President
Chan Zuckerberg Biohub Chicago
Sean Khozin, M.D.
CEO
CEO Roundtable on cancer
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
John Kulman, Ph.D.
CSO
Zag Bio
Gigi Kwik Gronvall, Ph.D.
Professor, Environmental Health and Engineering
Johns Hopkins Bloomberg School of Public Health
Shwetha Lakshmipathi, Ph.D.
Director
Institute for Follicular Lymphoma Innovation
Jennifer Lee
Venture Partner
CANCER FUND
John Lin, M.D., Ph.D.
SVP, Immuno-Oncology & Head of Bispecifics
Regeneron
Patrick Malone, M.D., PH.D.
Partner
KdT Ventures
Jonathan McClain
Executive Director
Eli Lilly
Brad Merrill, Ph.D.
Head of Innovation
Syntax Bio
Frank Nestle, M.D.
Partner and CEO, 3DC
Deerfield Management
Stephanie Oestreich, Ph.D.
Managing Director
Myeloma Investment Fund
Deborah Palestrant, Ph.D.
Executive Chair, 4:59 Initiative and Partner,
5AM Ventures
Paul Peloso, M.D.
Chief Medical Officer
COUR Pharmaceuticals
Eric Perreault, Ph.D.
VP, Research
Northwestern University
Koustubh Ranade, Ph.D.
SVP and Head of Translational Medicine
Immunocore
Venkat Reddy, Ph.D.
CSO
General Inception
Jessica Reed
VP Development
Diapin Therapeutics
Klaus Romero, M.D.
CEO
Critical Path Institute
Jean Rumsfield, Pharm.D.
Former Senior Director Global Alliance Management
Astellas Pharma
Justin Ryder, Ph.D.
Professor
Northwestern University Feinberg School of Medicine
Tay Salimullah
Venture Partner
4BIO Capital
Kate Sasser, Ph.D.
Chief Scientific Officer
Tempus AI
David Satijn, Ph.D.
SVP, Head of Discovery
Genmab
Jon Sedgwick, Ph.D.
SVP & Global Head Discovery
AbbVie
Evonne Sepsis
Managing Director
ESC Advisors
Ataali Shaikh
Head, Clinical Development Strategy & Solutions
Ubuntu Research
Adam Sonabend, M.D.
Associate Professor of Neurosurgery, Director of Translational Neuro-oncology,
Northwestern University
Stephen Susalka, Ph.D.
CEO
AUTM
Deepa Talpade, Ph.D.
VP, Head BD&L and Alliance Management, Oncology and Radiology
Bayer
Jody Thelander
Founder & CEO
J.Thelander Consulting
Morgan Thelander
Chief Operating Officer
J.Thelander Consulting
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Misti Ushio, Ph.D.
Managing Partner
Digitalis Ventures
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Anil Vasudevan, Ph.D.
Executive Director, Head - Technology & Therapeutic Platforms
AbbVie
Yurii Vlasov, Ph.D.
John Bardeen Chair, University of Illinois-Urbana Champaign & Head of Engineering,
Chan Zuckerberg Biohub
Daniel von Bornstädt, M.D.
Associate Partner
McKinsey & Company
Ben Weintraub, Ph.D.
President
inThought Research
John Wojcik, M.D., Ph.D.
Associate Vice President, Head, Translational Biomarkers
Merck Research Laboratories
Peter Wright, Ph.D.
Partner
McKinsey & Company
Shanshan Xu, M.D., Ph.D.
CEO
Bambusa Therapeutics
Guang Yang, Ph.D.
Partner
McKinsey & Company
Travis Young, Ph.D.
VP, Biologics
CALIBR, Scripps Research
Shann Yu, Ph.D.
Associate Director
AbbVie Ventures
Maziar Zarrehparvar
Fund Advisor
Kurma Partners